Literature DB >> 3723449

An empirical assessment of the migraine personality type.

F N Schmidt, P Carney, G Fitzsimmons.   

Abstract

The notion of a specific, measurable migraine personality type was empirically tested through the administration of the Jackson Personality Inventory (JPI) on 125 (103 female and 22 male) migraine subjects drawn from a biofeedback treatment/research project. A significant different (p less than 0.01) was identified between this group and the test norms on a simultaneous comparison of all 15 JPI variables (Hotelling T2 test). This difference was isolated along five variables (lower scores on the measures of Complexity, Risk Taking, and Social Participation and higher scores on the Responsibility and Value Orthodoxy scales). A post hoc profile analysis comparison of the female and male subjects revealed only a trend toward significance on one test, thereby supporting the assumption of no sex differences. While these findings are in line with some of the migraine personality literature support for many characteristics was not found (i.e. for the trait of anxiety).

Entities:  

Mesh:

Year:  1986        PMID: 3723449     DOI: 10.1016/0022-3999(86)90049-8

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  2 in total

1.  Stress in migraine: personality-dependent vulnerability, life events, and gender are of significance.

Authors:  Kerstin Hedborg; Ulla Maria Anderberg; Carin Muhr
Journal:  Ups J Med Sci       Date:  2011-06-14       Impact factor: 2.384

2.  The Rorschach Test Evaluation in Chronic Childhood Migraine: A Preliminary Multicenter Case-Control Study.

Authors:  Maria Esposito; Antonietta Messina; Vincenzo Monda; Ilaria Bitetti; Filomena Salerno; Francesco Precenzano; Simone Pisano; Tiziana Salvati; Antonella Gritti; Rosa Marotta; Serena Marianna Lavano; Francesco Lavano; Agata Maltese; Lucia Parisi; Margherita Salerno; Gabriele Tripi; Beatrice Gallai; Michele Roccella; Domenico Bove; Maria Ruberto; Roberto Toraldo; Giovanni Messina; Marco Carotenuto
Journal:  Front Neurol       Date:  2017-12-12       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.